Patent · US Active

Method of treating actinic keratosis

US8354424B2 · kind B2 · utility

0Cited by

66References

31Claims

0Family size

Assignee

MEDICON PHARMACEUTICALS, INC. · US

Inventors

James H. Lee · Devon, US
Terrance L. Fox · Oakdale, US

Key dates

Filing date	Mar 14, 2006
Grant date	Jan 15, 2013
Priority date	—
Expiry date	Dec 21, 2028

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K9/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating actinic keratosis including applying topically to an actinic keratosis lesion twice per week for a duration of 8 weeks a formulation comprising 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.